Treatment of inoperable lung carcinoma: a combined modality approach. 1979

H Takita, and A C Hollinshead, and D J Rizzo, and C M Kramer, and T Y Chen, and J N Bhayana, and F Edgerton

Twenty-four patients with inoperable lung carcinoma other than of the small cell type who received cis diamminedichloro platinum (II)-based combination chemotherapy were further treated with all available treatment modalities: radiation therapy, lung resection, chemotherapy, and immunotherapy. There were 2 operative deaths, and 2 patients died 6 and 8 months postoperatively of cardiac causes. Postmortem examination on these 4 patients revealed no evidence of residual tumor. The remaining 20 patients are alive 7 to 33 months from the onset of chemotherapy and 4 to 27 months following lung resection. These results, although preliminary, are encouraging, and further study is in progress.

UI MeSH Term Description Entries
D007167 Immunotherapy Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection. Immunotherapies
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas

Related Publications

H Takita, and A C Hollinshead, and D J Rizzo, and C M Kramer, and T Y Chen, and J N Bhayana, and F Edgerton
May 1977, Zeitschrift fur Krebsforschung und klinische Onkologie. Cancer research and clinical oncology,
H Takita, and A C Hollinshead, and D J Rizzo, and C M Kramer, and T Y Chen, and J N Bhayana, and F Edgerton
March 1985, Cancer treatment reports,
H Takita, and A C Hollinshead, and D J Rizzo, and C M Kramer, and T Y Chen, and J N Bhayana, and F Edgerton
December 2004, Lung cancer (Amsterdam, Netherlands),
H Takita, and A C Hollinshead, and D J Rizzo, and C M Kramer, and T Y Chen, and J N Bhayana, and F Edgerton
September 1979, European journal of cancer,
H Takita, and A C Hollinshead, and D J Rizzo, and C M Kramer, and T Y Chen, and J N Bhayana, and F Edgerton
March 1981, Archives of internal medicine,
H Takita, and A C Hollinshead, and D J Rizzo, and C M Kramer, and T Y Chen, and J N Bhayana, and F Edgerton
January 1976, Advances in pathobiology,
H Takita, and A C Hollinshead, and D J Rizzo, and C M Kramer, and T Y Chen, and J N Bhayana, and F Edgerton
March 2002, Clinical lung cancer,
H Takita, and A C Hollinshead, and D J Rizzo, and C M Kramer, and T Y Chen, and J N Bhayana, and F Edgerton
January 1988, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer,
H Takita, and A C Hollinshead, and D J Rizzo, and C M Kramer, and T Y Chen, and J N Bhayana, and F Edgerton
January 1998, The oncologist,
H Takita, and A C Hollinshead, and D J Rizzo, and C M Kramer, and T Y Chen, and J N Bhayana, and F Edgerton
May 2008, Reviews on recent clinical trials,
Copied contents to your clipboard!